---
title: "Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297696424.md"
description: "On September 1, 2026, AnaptysBio, Inc. revealed that Chris Murphy, their CFO, will be speaking at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. AnaptysBio primarily manages financial partnerships for Jemperli with GSK and imsidolimab with Vanda. The presentation is set to commence at 3:30pm ET. This company, listed on the Nasdaq as ANAB, focuses on collaborations in the pharmaceutical industry."
datetime: "2026-09-01T20:16:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297696424.md)
  - [en](https://longbridge.com/en/news/297696424.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297696424.md)
generator: "portal-rs"
---

# Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

On September 1, 2026, AnaptysBio, Inc. revealed that Chris Murphy, their CFO, will be speaking at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. AnaptysBio primarily manages financial partnerships for Jemperli with GSK and imsidolimab with Vanda. The presentation is set to commence at 3:30pm ET. This company, listed on the Nasdaq as ANAB, focuses on collaborations in the pharmaceutical industry.

### Related Stocks

- [ANAB.US](https://longbridge.com/en/quote/ANAB.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)
- [GSK.UK](https://longbridge.com/en/quote/GSK.UK.md)
- [GSK.WI.US](https://longbridge.com/en/quote/GSK.WI.US.md)

## Related News & Research

- [ANAB: Jemperli sales surged 34% year-over-year, fueling strong earnings and positive regulatory momentum](https://longbridge.com/en/news/299680376.md)
- [GSK Canada signs LOI with pCPA for Blenrep multiple myeloma coverage talks](https://longbridge.com/en/news/299753855.md)
- [Health Canada accepts GSK Jemperli review for dMMR/MSI-H locally advanced rectal cancer](https://longbridge.com/en/news/300026239.md)
- [GSK Bets on Long-Acting Biologics and AI to Reshape Respiratory Care](https://longbridge.com/en/news/299947794.md)
- [GSK Targets £40B Sales as Oncology Push and £1.9B Savings Plan Take Shape](https://longbridge.com/en/news/299877282.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**